Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease, with a prevalence that is increasing in parallel with the global rise in obesity and type 2 diabetes mellitus. The pathogenesis of NAFLD is complex and multifactorial, involving environmental, genetic and metabolic factors. The role of the diet and the gut microbiome is gaining interest as a significant factor in NAFLD pathogenesis. Dietary factors induce alterations in the composition of the gut microbiome (dysbiosis), commonly reflected by a reduction of the beneficial species and an increase in pathogenic microbiota. Due to the close relationship between the gut and liver, altering the gut microbiome can affect liver functions; promoting hepatic steatosis and inflammation. This review summarises the current evidence supporting an association between NAFLD and the gut microbiome and dietary factors. The review also explores potential underlying mechanisms underpinning these associations and whether manipulation of the gut microbiome is a potential therapeutic strategy to prevent or treat NAFLD.
Citations
Citations to this article as recorded by
A Review of the Gut Microbiome and Its Role in Non-alcoholic Fatty Liver Disease Fahad Alfhaid Advances in Human Biology.2026; 16(1): 11. CrossRef
Low Serum sRAGE and MASLD Are Associated and Share a Similar Gut Microbiota Profile: A Prospective and Cross‐Sectional Analysis Laura Sol Grinshpan, Dana Ivancovsky‐Wajcman, Oren Tirosh, Michal Verman, Naomi Fliss‐Isakov, Muriel Webb, Oren Shibolet, Maya Ofek‐Lalzar, Revital Kariv, Shira Zelber‐Sagi Liver International.2026;[Epub] CrossRef
10-hydroxy-2(E)-decenoic acid attenuates metabolic dysfunction–associated steatotic liver disease via modulation of the gut microbiota–bile acid–FXR axis Xinyu Yu, Meifei Zhu, Kangli Wang, Bin Yuan, Yuanyuan Lu, Shanshan Li, Fuliang Hu Food Bioscience.2026; 78: 108532. CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa Mohamed El-Kassas, C. Wendy Spearman, Manal El-Sayed, Zobair M. Younossi Clinics in Liver Disease.2026;[Epub] CrossRef
Gut-Derived Hippuric Acid Alleviates Hepatic Lipid Metabolism via UGDH/FOXK1/CD36 Axis in Obese Mice Shuai Chen, Jiaming Xue, Yuancheng Shao, Hanyang Liu, Fangmin Zhou, Xihan Gu, Gang Zhou, Tianhan Xu, Dongmei Wang, Liming Tang Drug Design, Development and Therapy.2026; Volume 20: 1. CrossRef
Supragingival
Actinomyces naeslundii
aggravates metabolic dysfunction-associated fatty liver disease via the oral–gut axis
Ye Tu, Zhanyi Chen, Meiling Jing, Wenduo Tan, Danni Huang, Jin Xu, Min Wang, Hao Li, Yueyi Yang, Xiaoyu Liu, Xuchen Hu, Yihuai Pan, Chenguang Niu, Zhengwei Huang Journal of Oral Microbiology.2026;[Epub] CrossRef
Multistrain Probiotics Alleviate Diarrhea by Modulating Microbiome-Derived Metabolites and Serotonin Pathway Jin-Ju Jeong, Yoo-Jeong Jin, Raja Ganesan, Hee Jin Park, Byeong Hyun Min, Min Kyo Jeong, Sang Jun Yoon, Mi Ran Choi, Satya Priya Sharma, You Jin Jang, Uigi Min, Jong-Hyun Lim, Kyeong Min Na, Jieun Choi, Sang Hak Han, Young Lim Ham, Do Yup Lee, Byung-Yong Probiotics and Antimicrobial Proteins.2025; 17(5): 2894. CrossRef
The causal relationship of cigarette smoking to metabolic disease risk and the possible mediating role of gut microbiota Jingda Zhang, Lin Hou, Shanxiang Lei, Yan Li, Guogang Xu Ecotoxicology and Environmental Safety.2025; 290: 117522. CrossRef
SMALL INTESTINAL BACTERIAL OVERGROWTH IN THE INTESTINE AND MICROBIOME ALTERATIONS AS A RISK FACTOR FOR LIPID METABOLISM DISORDERS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE Kh. B. Kvit, N. V. Kharchenko Art of Medicine.2025; : 38. CrossRef
Exploration of Early Diagnostic Biomarkers for Intestinal Barrier Dysfunction in Non-Alcoholic Fatty Liver Disease 庄巍 李 Advances in Clinical Medicine.2025; 15(02): 315. CrossRef
Synbiotic combination of fructooligosaccharides and probiotics ameliorates the metabolic dysfunction-associated steatotic liver disease Sang Yoon Lee, Su-Been Lee, Goo-Hyun Kwon, Seol Hee Song, Jeong Ha Park, Min Ju Kim, Jung A Eom, Kyeong Jin Lee, Sang Jun Yoon, Hyunjoon Park, Sung-Min Won, Jin-Ju Jeong, Ki-Kwang Oh, Young Lim Ham, Gwang Ho Baik, Dong Joon Kim, Satya Priya Sharma, Ki Tae Journal of Microbiology.2025; 63(2): e2411002. CrossRef
Gut microbiome alterations in immune thrombocytopenia: a systematic review of current evidence Alireza Khiabani, Roohollah Mirzaee Khalilabadi, Hajar Mardani Valandani, Zahra Khoshnegah, Alireza Khanahmad, Hojat Shahraki, Najmeh Nezamabadipour, Alireza Farsinejad, Mehran Rahimlou Frontiers in Medicine.2025;[Epub] CrossRef
The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma Sang Jun Yoon, Seul Ki Han, Tae Suk Kim, Ki Tae Suk, Dae Hee Choi, Young Don Kim, Moon Young Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim Critical Reviews in Microbiology.2025; 51(6): 1315. CrossRef
The newly proposed dietary index for gut microbiota and its association with the risk of nonalcoholic fatty liver disease: the mediating role of body mass index Shengnan Meng, Luonan Li, Shijie Yin, Yuxuan Zhao, Yaning Liu, Yuxi Zhang, Xiaolin Zhang, Fengxue Yu Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
Gut microbiota and metabolomics in metabolic dysfunction-associated fatty liver disease: interaction, mechanism, and therapeutic value Luyu Wang, Hongtao Wang, Jian Wu, Changyi Ji, Ying Wang, Mengmeng Gu, Miaomiao Li, Hongwei Yang Frontiers in Cellular and Infection Microbiology.2025;[Epub] CrossRef
Phocaeicola dorei
ameliorates progression of steatotic liver disease by regulating bile acid, lipid, inflammation and proliferation
Jieun Choi, Ye Rin Choi, Min Kyo Jeong, Hyun Ho Song, Jeong Seok Yu, Seol Hui Song, Jeong Ha Park, Min Ju Kim, Hyunjoon Park, Young Lim Ham, Sang Hak Han, Dong Joon Kim, Do Yup Lee, Ki Tae Suk Gut Microbes.2025;[Epub] CrossRef
Fibroblast growth factor receptor inhibitors ameliorate metabolic dysfunction-associated steatohepatitis by modulating the glycine-glutathione-gut microbiota axis Hailong Li, Xiaoman Ye, Yayue Hu, Yingjun Wang, Yuting Ding, Ying Yang, Ruiqi Mao, Xi Wu, Huixuan Dong, Kaijun Qiu, Xiaohe Li, Honggang Zhou, Guang Yang, Fubao Zhang, Cheng Yang Free Radical Biology and Medicine.2025; 240: 410. CrossRef
Visiting MASLD through the lens of sex, immunity, and microbial interactions Snehanjali Puhan, Smaroki Smruti Rekha, Kartika Sahu, Tanuja Mohanty, Arka Jyoti De, Ankita Das, Palok Aich Discover Medicine.2025;[Epub] CrossRef
The AhR/IL-22 axis in chronic gut inflammation: unraveling mechanisms and therapeutic prospects Huimin Kang, Zheng Chen, Baodong Wang, Zhiyun Chen Frontiers in Immunology.2025;[Epub] CrossRef
Food Minor Bioactive Compounds of Polyphenolic and Polyprenolic Nature Are Promising Agents for the Prevention and Therapy of Non-Alcoholic Fatty Liver Disease Anastasiya Balakina, Yuliya Sidorova, Nikita Petrov, Vladimir Shipelin Molecules.2025; 30(18): 3791. CrossRef
From liver to gut: the hidden gastrointestinal impact of pediatric metabolic dysfunction-associated steatotic liver disease Gianmario Forcina, Vittoria Frattolillo, Maria De Cesare, Assunta Floriano, Rosamaria Palma, Federica Casamassima, Mario Bartiromo, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa Expert Review of Gastroenterology & Hepatology.2025; 19(12): 1329. CrossRef
Ultra-processed food consumption and non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance: A systematic review Laura Sol Grinshpan, Sigal Eilat-Adar, Dana Ivancovsky-Wajcman, Revital Kariv, Michal Gillon-Keren, Shira Zelber-Sagi JHEP Reports.2024; 6(1): 100964. CrossRef
Healthy diet intervention reverses the progression of NASH through gut microbiota modulation Suraphan Panyod, Wei-Kai Wu, Meng-Yun Hu, Huai-Syuan Huang, Rou-An Chen, Yi-Hsun Chen, Ting-Chin David Shen, Chi-Tang Ho, Chun-Jen Liu, Hsiao-Li Chuang, Chi-Chang Huang, Ming-Shiang Wu, Lee-Yan Sheen, Wei-Hua Chen Microbiology Spectrum.2024;[Epub] CrossRef
The Current and Future State of Microbiome Therapeutics in Liver Disease Patricia P. Bloom, Jasmohan S. Bajaj American Journal of Gastroenterology.2024; 119(1S): S36. CrossRef
Emerging Drug Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Glimpse into the Horizon Jorge Arnold, Francisco Idalsoaga, Luis Antonio Díaz, Daniel Cabrera, Francisco Barrera, Juan Pablo Arab, Marco Arrese Current Hepatology Reports.2024; 23(1): 204. CrossRef
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation Byeong Hyun Min, Shivani Devi, Goo Hyun Kwon, Haripriya Gupta, Jin-Ju Jeong, Satya Priya Sharma, Sung-Min Won, Ki-Kwang Oh, Sang Jun Yoon, Hee Jin Park, Jung A Eom, Min Kyo Jeong, Ji Ye Hyun, Nattan Stalin, Tae-Sik Park, Jieun Choi, Do Yup Lee, Sang Hak H Gut Microbes.2024;[Epub] CrossRef
Food for thought: Making the case for food produced via regenerative agriculture in the battle against non-communicable chronic diseases (NCDs) Davendra Ramkumar, Aileen Marty, Japhia Ramkumar, Holly Rosencranz, Radhika Vedantham, Modan Goldman, Erin Meyer, Jasia Steinmetz, Amy Weckle, Kelly Bloedorn, Carl Rosier One Health.2024; 18: 100734. CrossRef
Gestational supplementation of Bifidobacterium, Lactobacillus, and Streptococcus thermophilus attenuates hepatic steatosis in offspring mice through promoting fatty acid β‐oxidation Hangjun Chen, Qiongmei Wu, Xingyi Chen, Xinxue Yu, Hanqing Zhao, Qiaoli Huang, Yurong Huang, Jinting Wang, Xueyi Huang, Jun Wei, Feng Wu, Xiaomin Xiao, Lijun Wang Journal of Food Science.2024; 89(5): 3064. CrossRef
Small intestinal bacterial overgrowth in obese patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: a cross-sectional study Nicolás Ortiz-López, Ana María Madrid, Larissa Aleman, Alejandra Zazueta, Gladys Smok, Lucía Valenzuela-Pérez, Jaime Poniachik, Caroll J. Beltrán Frontiers in Medicine.2024;[Epub] CrossRef
Developmental Programming of the Fetal Immune System by Maternal Western-Style Diet: Mechanisms and Implications for Disease Pathways in the Offspring Benjamin N. Nelson, Jacob E. Friedman International Journal of Molecular Sciences.2024; 25(11): 5951. CrossRef
Quantification of gut microbiome metabolites using chemical isotope derivatization strategy combined with LC-MS/MS: Application in neonatal hypoxic-ischemic encephalopathy rat model Fangbo Xia, Peng Cui, Ling Liu, Junhe Chen, Qiqi Zhou, Qian Wang, Hongwei Zhou Journal of Pharmaceutical and Biomedical Analysis.2024; 248: 116312. CrossRef
An examination of global research trends for exploring the associations between the gut microbiota and nonalcoholic fatty liver disease through bibliometric and visualization analysis Sa’ed H. Zyoud, Samer O. Alalalmeh, Omar E. Hegazi, Muna Shakhshir, Faris Abushamma, Samah W. Al-Jabi Gut Pathogens.2024;[Epub] CrossRef
Gut Dysbiosis Shaped by Cocoa Butter-Based Sucrose-Free HFD Leads to Steatohepatitis, and Insulin Resistance in Mice Shihab Kochumon, Md. Zubbair Malik, Sardar Sindhu, Hossein Arefanian, Texy Jacob, Fatemah Bahman, Rasheeba Nizam, Amal Hasan, Reeby Thomas, Fatema Al-Rashed, Steve Shenouda, Ajit Wilson, Shaima Albeloushi, Nourah Almansour, Ghadeer Alhamar, Ashraf Al Madh Nutrients.2024; 16(12): 1929. CrossRef
Ginger essential oil prevents NASH progression by blocking the NLRP3 inflammasome and remodeling the gut microbiota-LPS-TLR4 pathway in mice Suraphan Panyod, Wei-Kai Wu, Ya-Chi Hsieh, Yea-Jing Tseng, Sin-Yi Peng, Rou-An Chen, Huai-Syuan Huang, Yi-Hsun Chen, Ting-Chin David Shen, Chi-Tang Ho, Chun-Jen Liu, Hsiao-Li Chuang, Chi-Chang Huang, Ming-Shiang Wu, Lee-Yan Sheen Nutrition & Diabetes.2024;[Epub] CrossRef
Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression Chao Yang, Jiale Wu, Ligang Yang, Qiaosheng Hu, Lihua Li, Yafang Yang, Jing Hu, Da Pan, Qing Zhao Scientific Reports.2024;[Epub] CrossRef
Regulation of endotoxemia through the gut microbiota: The role of the Mediterranean diet and its components Jing Kong, Juan Yang, Cong He, Bingduo Zhou, Shengquan Fang, Manisha Salinas, Arya B. Mohabbat, Brent A. Bauer, Xiaosu Wang APMIS.2024; 132(12): 948. CrossRef
Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications, and therapeutic potentials Naveen Jeyaraman, Madhan Jeyaraman, Tejaswin Mariappan, Sathish Muthu, Swaminathan Ramasubramanian, Shilpa Sharma, Gabriel Silva Santos, Lucas Furtado da Fonseca, José Fábio Lana World Journal of Gastrointestinal Pharmacology and Therapeutics.2024;[Epub] CrossRef
Stage dependent microbial dynamics in hepatocellular carcinoma and adjacent normal liver tissues Hee Eun Jo, Sophallika Khom, Sumi Lee, Su Hyeon Cho, Shin Young Park, Ga Ram You, Hyosin Kim, Nah Ihm Kim, Jae-Ho Jeong, Jae Hyun Yoon, Misun Yun Scientific Reports.2024;[Epub] CrossRef
Convergence of Alcohol Consumption and Dietary Quality in US Adults Who Currently Drink Alcohol: An Analysis of Two Core Risk Factors of Liver Disease Peng-Sheng Ting, Wei-Ting Lin, Suthat Liangpunsakul, Madeline Novack, Chiung-Kuei Huang, Hui-Yi Lin, Tung-Sung Tseng, Po-Hung Chen Nutrients.2024; 16(22): 3866. CrossRef
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease Luis Antonio Díaz, Juan Pablo Arab, Alexandre Louvet, Ramón Bataller, Marco Arrese Nature Reviews Gastroenterology & Hepatology.2023; 20(12): 764. CrossRef
Elevated serum levels of diamine oxidase, D-lactate and lipopolysaccharides are associated with metabolic-associated fatty liver disease Ruike Zhang, Ya-nan Chen, Jixia Zhang, Jing Liu European Journal of Gastroenterology & Hepatology.2023; 35(1): 94. CrossRef
Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol Ming Yang, Xiaoqiang Qi, Nan Li, Jussuf T. Kaifi, Shiyou Chen, Andrew A. Wheeler, Eric T. Kimchi, Aaron C. Ericsson, R. Scott Rector, Kevin F. Staveley-O’Carroll, Guangfu Li Nature Communications.2023;[Epub] CrossRef
The identification of metabolites from gut microbiota in NAFLD via network pharmacology Ki-Kwang Oh, Haripriya Gupta, Byeong Hyun Min, Raja Ganesan, Satya Priya Sharma, Sung Min Won, Jin Ju Jeong, Su Been Lee, Min Gi Cha, Goo Hyun Kwon, Min Kyo Jeong, Ji Ye Hyun, Jung A Eom, Hee Jin Park, Sang Jun Yoon, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk Scientific Reports.2023;[Epub] CrossRef
Comparison between obese and non-obese nonalcoholic fatty liver disease Wah-Kheong Chan Clinical and Molecular Hepatology.2023; 29(Suppl): S58. CrossRef
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology Eileen Laurel Yoon, Dae Won Jun Clinical and Molecular Hepatology.2023; 29(2): 371. CrossRef
MicroRNA‐29a Compromises Hepatic Adiposis and Gut Dysbiosis in High Fat Diet‐Fed Mice via Downregulating Inflammation Ya‐Ling Yang, Ying‐Hsien Huang, Feng‐Sheng Wang, Ming‐Chao Tsai, Chien‐Hung Chen, Wei‐Shiung Lian Molecular Nutrition & Food Research.2023;[Epub] CrossRef
Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2/HO-1 and gut microbiota Ahmed M. El-Baz, Amira M. El-Ganiny, Doaa Hellal, Hala M. Anwer, Hend A. Abd El-Aziz, Ibrahim E. Tharwat, Mohamed A. El-Adawy, Shehab El-Din M. Helal, Menna Tallah A. Mohamed, Tassnim M. Azb, Hanya M. Elshafaey, AbdulRahman A. Shalata, Sahar M. Elmeligi, AMB Express.2023;[Epub] CrossRef
Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patients Christoph Roderburg, Sarah Krieg, Andreas Krieg, Sascha Vaghiri, Raphael Mohr, Marcel Konrad, Mark Luedde, Tom Luedde, Karel Kostev, Sven H. Loosen Clinical Research in Cardiology.2023; 112(10): 1446. CrossRef
Blueberry and Blackberry Anthocyanins Ameliorate Metabolic Syndrome by Modulating Gut Microbiota and Short-Chain Fatty Acids Metabolism in High-Fat Diet-Fed C57BL/6J Mice Lanlan Du, Han Lü, Yan Chen, Xiaohua Yu, Tunyu Jian, Huifang Zhao, Wenlong Wu, Xiaoqin Ding, Jian Chen, Weilin Li Journal of Agricultural and Food Chemistry.2023; 71(40): 14649. CrossRef
The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status Josip Stojic, Michał Kukla, Ivica Grgurevic Diagnostics.2023; 13(18): 2960. CrossRef
Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease” Eileen L. Yoon, Dae Won Jun Clinical and Molecular Hepatology.2023; 29(4): 1050. CrossRef
A High-Fat Diet Increases the Characteristics of Gut Microbial Composition and the Intestinal Damage Associated with Non-Alcoholic Fatty Liver Disease Xiaoyang Zhu, Jiajia Cai, Yifu Wang, Xinyu Liu, Xiaolei Chen, Haifei Wang, Zhengchang Wu, Wenbin Bao, Hairui Fan, Shenglong Wu International Journal of Molecular Sciences.2023; 24(23): 16733. CrossRef
Preventive Effects of Apple Polyphenol Extract on High-Fat-Diet-Induced Hepatic Steatosis Are Related to the Regulation of Hepatic Lipid Metabolism, Autophagy, and Gut Microbiota in Aged Mice Yan Yin, Yisha Xie, Zhengli Wu, Qingfan Qian, Hao Yang, Shilan Li, Xinli Li Journal of Agricultural and Food Chemistry.2023; 71(50): 20011. CrossRef
Design and Usability Evaluation of a Self-Care Application for Non-Alcoholic Fatty Liver Disease Patients with Overweight: Approach Leveraging Behavior Change Techniques (Preprint) Azam Kheirdoust, Mohammad Reza Mazaheri Habibi, Mohsen Nematy, Ali Jafarzadeh Esfahani, Kosar Ghaddaripour, Saeid Eslami JMIR Human Factors.2023;[Epub] CrossRef
The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases Lingxuan An, Ulrich Wirth, Dominik Koch, Malte Schirren, Moritz Drefs, Dionysios Koliogiannis, Hanno Nieß, Joachim Andrassy, Markus Guba, Alexandr V. Bazhin, Jens Werner, Florian Kühn Journal of Gastrointestinal Surgery.2022; 26(3): 671. CrossRef
Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease Alessandro Mantovani, Christopher D. Byrne, Giovanni Benfari, Stefano Bonapace, Tracey G. Simon, Giovanni Targher Journal of the American College of Cardiology.2022; 79(2): 180. CrossRef
Oxidative Stress in Non-Alcoholic Fatty Liver Disease Carlo Smirne, Eleonora Croce, Davide Di Benedetto, Vincenzo Cantaluppi, Cristoforo Comi, Pier Paolo Sainaghi, Rosalba Minisini, Elena Grossini, Mario Pirisi Livers.2022; 2(1): 30. CrossRef
Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and Incidence of Heart Failure in the Korean Population: A Nationwide Cohort Study Byoungduck Han, Gyu Bae Lee, Sun Young Yim, Kyung-Hwan Cho, Koh Eun Shin, Jung-Hwan Kim, Yong-Gyu Park, Kyung-Do Han, Yang-Hyun Kim Diagnostics.2022; 12(3): 663. CrossRef
Pterostilbene and Its Derivative 3′-Hydroxypterostilbene Ameliorated Nonalcoholic Fatty Liver Disease Through Synergistic Modulation of the Gut Microbiota and SIRT1/AMPK Signaling Pathway Hui-Yun Tsai, Yu-Yuan Shih, Yao-Tsung Yeh, Cheng-Hsieh Huang, Chorng-An Liao, Chun-Yi Hu, Kalyanam Nagabhushanam, Chi-Tang Ho, Yu-Kuo Chen Journal of Agricultural and Food Chemistry.2022; 70(16): 4966. CrossRef
The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats Yufan Dai, Wenyu Zhu, Jiaxuan Zhou, Tao Shen Brazilian Journal of Medical and Biological Research.2022;[Epub] CrossRef
Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study Dong Hyun Sinn, Danbee Kang, Mira Kang, Eliseo Guallar, Yun Soo Hong, Kyung Hyun Lee, Jiyeon Park, Juhee Cho, Geum‐Youn Gwak Hepatology.2022; 76(6): 1746. CrossRef
The Role of Rumen Microbiota and Its Metabolites in Subacute Ruminal Acidosis (SARA)-Induced Inflammatory Diseases of Ruminants Yunhe Fu, Yuhong He, Kaihe Xiang, Caijun Zhao, Zhaoqi He, Min Qiu, Xiaoyu Hu, Naisheng Zhang Microorganisms.2022; 10(8): 1495. CrossRef
Oral administration of branched-chain amino acids ameliorates high-fat diet-induced metabolic-associated fatty liver disease via gut microbiota-associated mechanisms Ranran Zhang, Hongna Mu, Ziyun Li, Jie Zeng, Qi Zhou, Hongxia Li, Siming Wang, Xianghui Li, Xianghui Zhao, Liang Sun, Wenxiang Chen, Jun Dong, Ruiyue Yang Frontiers in Microbiology.2022;[Epub] CrossRef
Effect of metabolic dysfunction‐associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide study Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin‐Ha Yoon, Beom Kyung Kim Hepatology Research.2022; 52(12): 975. CrossRef
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis Yu-Lin Zhang, Zhen-Jiao Li, Hong-Zhong Gou, Xiao-Jing Song, Lei Zhang Frontiers in Cellular and Infection Microbiology.2022;[Epub] CrossRef
The role of the intestinal permeability in the progression of nonalcoholic fatty liver disease in obese children Yu.M. Stepanov, N.Yu. Zavhorodnia, N.O. Zhyhyr GASTROENTEROLOGY.2022; 56(1): 20. CrossRef
The Gut-Liver Axis in Cholestatic Liver Diseases Andreas Blesl, Vanessa Stadlbauer Nutrients.2021; 13(3): 1018. CrossRef
Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease Joo Hyun Oh, Je Hee Lee, Min Seok Cho, Hyeree Kim, Jongsik Chun, Joon Hyeok Lee, Yeup Yoon, Wonseok Kang Nutrients.2021; 13(3): 1013. CrossRef
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach Giovanni Targher, Herbert Tilg, Christopher D Byrne The Lancet Gastroenterology & Hepatology.2021; 6(7): 578. CrossRef
CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload Riina Harjumäki, Chris S. Pridgeon, Magnus Ingelman-Sundberg International Journal of Molecular Sciences.2021; 22(15): 8221. CrossRef
Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases Satya Priya Sharma, Ki Tae Suk, Dong Joon Kim World Journal of Gastroenterology.2021; 27(37): 6161. CrossRef
Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa C Wendy Spearman, Mary Afihene, Omolade Betiku, Bilal Bobat, Lina Cunha, Chris Kassianides, Leolin Katsidzira, Hailemichael D Mekonnen, Ponsiano Ocama, Olusegun Ojo, Imran Paruk, Christian Tzeuton, Mark W Sonderup The Lancet Gastroenterology & Hepatology.2021; 6(12): 1036. CrossRef
Diet-Regulating Microbiota and Host Immune System in Liver Disease Jung A Eom, Goo Hyun Kwon, Na Yeon Kim, Eun Ju Park, Sung Min Won, Jin Ju Jeong, Ganesan Raja, Haripriya Gupta, Yoseph Asmelash Gebru, Satyapriya Sharma, Ye Rin Choi, Hyeong Seop Kim, Sang Jun Yoon, Ji Ye Hyun, Min Kyo Jeong, Hee Jin Park, Byeong Hyun Min International Journal of Molecular Sciences.2021; 22(12): 6326. CrossRef
Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease Li-Hong He, Dun-Han Yao, Ling-Yun Wang, Lei Zhang, Xue-Li Bai Frontiers in Microbiology.2021;[Epub] CrossRef
INSULIN RESISTANCE AS AN INDICATOR OF DIFFERENTIATION FOR THE FORMATION OF RISK GROUPS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITHOUT TYPE 2 DIABETES MELLITUS, AS A PART OF ONTOLOGICAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE Natalia O. Nosko, Viacheslav V. Kharchenko Wiadomości Lekarskie.2021; 74(10): 2593. CrossRef
Dual role of neutrophils in modulating liver injury and fibrosis during development and resolution of diet-induced murine steatohepatitis Andrea D. Kim, Sung Eun Kim, Aleksandra Leszczynska, Benedikt Kaufmann, Agustina Reca, Dong Joon Kim, Ariel E. Feldstein Scientific Reports.2021;[Epub] CrossRef
Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection Yi Jiang, Salil Chowdhury, Bing-Hong Xu, Mohamad Aghaie Meybodi, Konstantinos Damiris, Samanthika Devalaraju, Nikolaos Pyrsopoulos World Journal of Hepatology.2021; 13(11): 1777. CrossRef
First
Prev
